GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OSTO:CAMX) » Definitions » Interest Coverage

Camurus AB (OSTO:CAMX) Interest Coverage : 584.74 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Camurus AB's Operating Income for the three months ended in Dec. 2024 was kr166 Mil. Camurus AB's Interest Expense for the three months ended in Dec. 2024 was kr-0 Mil. Camurus AB's interest coverage for the quarter that ended in Dec. 2024 was 584.74. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Camurus AB has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Camurus AB's Interest Coverage or its related term are showing as below:

OSTO:CAMX' s Interest Coverage Range Over the Past 10 Years
Min: 58.8   Med: 392.76   Max: 432.81
Current: 432.81


OSTO:CAMX's Interest Coverage is ranked better than
54.36% of 344 companies
in the Biotechnology industry
Industry Median: 158.54 vs OSTO:CAMX: 432.81

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Camurus AB Interest Coverage Historical Data

The historical data trend for Camurus AB's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Camurus AB Interest Coverage Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 58.80 392.76 432.81

Camurus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 273.14 298.22 603.52 584.74

Competitive Comparison of Camurus AB's Interest Coverage

For the Biotechnology subindustry, Camurus AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Camurus AB's Interest Coverage falls into.



Camurus AB Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Camurus AB's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, Camurus AB's Interest Expense was kr-1 Mil. Its Operating Income was kr469 Mil. And its Long-Term Debt & Capital Lease Obligation was kr7 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2024 )/Interest Expense (A: Dec. 2024 )
=-1*469.165/-1.084
=432.81

Camurus AB's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, Camurus AB's Interest Expense was kr-0 Mil. Its Operating Income was kr166 Mil. And its Long-Term Debt & Capital Lease Obligation was kr7 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*166.067/-0.284
=584.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Camurus AB  (OSTO:CAMX) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Camurus AB Interest Coverage Related Terms

Thank you for viewing the detailed overview of Camurus AB's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines